表紙
市場調查報告書

多發性硬化症(MS)治療藥的全球市場的預測

Multiple Sclerosis Drugs Market Global Report 2020-30

出版商 The Business Research Company 商品編碼 931973
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
多發性硬化症(MS)治療藥的全球市場的預測 Multiple Sclerosis Drugs Market Global Report 2020-30
出版日期: 2020年04月10日內容資訊: 英文
簡介

本報告提供全球多發性硬化症(MS)治療藥市場調查,提供市場概要,各醫藥品分類·流通管道·給藥途徑·主要各地各國的市場規模的變化與預測(過去5年·今後10年份),市場佔有率,成長率,市場成長要素及阻礙因素分析,近幾年主要的合併·收購(M&A)趨勢,市場策略,成長的預測投資領域,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場規模與成長率

  • 市場規模(實際成果值)
    • 市場成長要素
    • 市場阻礙因素
  • 市場規模(預測值)
    • 市場成長要素
    • 市場阻礙因素

第4章 多發性硬化症(MS)治療藥的全球市場:各市場區隔

  • 市場規模:各醫藥品分類(實際成果值·預測值)
    • 免疫調節劑
    • 免疫抑制劑
    • 干擾素
    • 其他
  • 市場規模:各流通管道(實際成果值·預測值)
    • 醫院藥局
    • 零售藥局
    • 網路商店
  • 市場規模:各給藥途徑(實際成果值·預測值)
    • 口服給藥
    • 非口服給藥

第5章 多發性硬化症(MS)治療藥市場分析:各地各國

  • 市場規模:各地區(實際成果值·預測值)
  • 市場規模:各國(實際成果值·預測值)

第6章 亞太地區的多發性硬化症(MS)治療藥市場

  • 市場概要
  • 市場規模:各醫藥品分類(實際成果值·預測值)
  • 市場規模:各流通管道(實際成果值·預測值)

第7章 中國的多發性硬化症(MS)治療藥市場

第8章 印度的多發性硬化症(MS)治療藥市場

第9章 日本的多發性硬化症(MS)治療藥市場

第10章 澳洲的多發性硬化症(MS)治療藥市場

第11章 印尼的多發性硬化症(MS)治療藥市場

第12章 韓國的多發性硬化症(MS)治療藥市場

第13章 西歐的多發性硬化症(MS)治療藥市場

第14章 英國的多發性硬化症(MS)治療藥市場

第15章 德國的多發性硬化症(MS)治療藥市場

第16章 法國的多發性硬化症(MS)治療藥市場

第17章 東歐的多發性硬化症(MS)治療藥市場

第18章 俄羅斯的多發性硬化症(MS)治療藥市場

第19章 北美的多發性硬化症(MS)治療藥市場

第20章 美國的多發性硬化症(MS)治療藥市場

第21章 南美的多發性硬化症(MS)治療藥市場

第22章 巴西的多發性硬化症(MS)治療藥市場

第23章 中東的多發性硬化症(MS)治療藥市場

第24章 非洲的多發性硬化症(MS)治療藥市場

第25章 競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • Biogen
    • Novartis
    • Roche
    • Bayer HealthCare
    • Pfizer, Inc.

第26章 主要合併·收購(M&A)趨勢

第27章 市場趨勢與策略

第28章 市場展望與潛在性分析

第29章 附錄

目錄

‘Multiple Sclerosis Drugs Market Global Report 2020-30 ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global multiple sclerosis drugs market.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the multiple sclerosis drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? ‘The Multiple Sclerosis Drugs market global report ’ from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider multiple sclerosis drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The multiple sclerosis drugs market section of the report gives context. It compares the multiple sclerosis drugs market with other segments of the multiple sclerosis drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, multiple sclerosis drugs indicators comparison.

Scope:

Markets Covered: 1) By Drug Class: Immunomodulators; Immunosuppressants; Interferons; Others

2) By Distribution Channels: Hospital Pharmacy; Retail Pharmacy; Online Stores

3) By Route Of Administration: Oral Drugs; Parenteral Drugs

Companies Mentioned: Biogen; Novartis; Roche; Bayer HealthCare; Pfizer, Inc.

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Multiple Sclerosis Drugs Market Characteristics

3. Multiple Sclerosis Drugs Market Size And Growth

  • 3.1. Global Multiple Sclerosis Drugs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Multiple Sclerosis Drugs Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Multiple Sclerosis Drugs Market Segmentation

  • 4.1. Global Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Immunomodulators

Immunosuppressants

Interferons

Others

  • 4.2. Global Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Stores

  • 4.3. Global Multiple Sclerosis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral drugs

Parenteral drugs

5. Multiple Sclerosis Drugs Market Regional And Country Analysis

  • 5.1. Global Multiple Sclerosis Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Multiple Sclerosis Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Multiple Sclerosis Drugs Market

  • 6.1. Asia-Pacific Multiple Sclerosis Drugs Market Overview
  • 6.2. Asia-Pacific Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Multiple Sclerosis Drugs Market

  • 7.1. China Multiple Sclerosis Drugs Market Overview
  • 7.2. China Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Multiple Sclerosis Drugs Market

  • 8.1. India Multiple Sclerosis Drugs Market Overview
  • 8.2. India Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Multiple Sclerosis Drugs Market

  • 9.1. Japan Multiple Sclerosis Drugs Market Overview
  • 9.2. Japan Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Multiple Sclerosis Drugs Market

  • 10.1. Australia Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Multiple Sclerosis Drugs Market

  • 11.1. Indonesia Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Multiple Sclerosis Drugs Market

  • 12.1. South Korea Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Multiple Sclerosis Drugs Market

  • 13.1. Western Europe Multiple Sclerosis Drugs Market Overview
  • 13.2. Western Europe Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Multiple Sclerosis Drugs Market

  • 14.1. UK Multiple Sclerosis Drugs Market Overview
  • 14.2. UK Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Multiple Sclerosis Drugs Market

  • 15.1. Germany Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Multiple Sclerosis Drugs Market

  • 16.4. France Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Multiple Sclerosis Drugs Market

  • 17.1. Eastern Europe Multiple Sclerosis Drugs Market Overview
  • 17.2. Eastern Europe Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Multiple Sclerosis Drugs Market

  • 18.1. Russia Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Multiple Sclerosis Drugs Market

  • 19.1. North America Multiple Sclerosis Drugs Market Overview
  • 19.2. North America Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Multiple Sclerosis Drugs Market

  • 20.1. USA Multiple Sclerosis Drugs Market Overview
  • 20.2. USA Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Multiple Sclerosis Drugs Market

  • 21.1. South America Multiple Sclerosis Drugs Market Overview
  • 21.2. South America Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Multiple Sclerosis Drugs Market

  • 22.1. Brazil Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Multiple Sclerosis Drugs Market

  • 23.1. Middle East Multiple Sclerosis Drugs Market Overview
  • 23.2. Middle East Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Multiple Sclerosis Drugs Market

  • 24.1. Africa Multiple Sclerosis Drugs Market Overview
  • 24.2. Africa Multiple Sclerosis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Multiple Sclerosis Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Multiple Sclerosis Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Multiple Sclerosis Drugs Market Competitive Landscape
  • 25.2. Multiple Sclerosis Drugs Market Company Profiles
    • 25.2.1. Biogen
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Novartis
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Roche
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Bayer HealthCare
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Pfizer, Inc.
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Multiple Sclerosis Drugs Market

27. Multiple Sclerosis Drugs Market Trends And Strategies

28. Multiple Sclerosis Drugs Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer